| Literature DB >> 27995084 |
Masatoshi Kudo1, Franco Trevisani2, Ghassan K Abou-Alfa3, Lorenza Rimassa4.
Abstract
Western and Eastern perspectives on therapeutic guidelines for hepatocellular carcinoma (HCC) have many commonalities but may also differ in certain aspects, as described in this article. In view of the limited therapeutic options for advanced HCC, evidence-based therapies are few, and thus there is a dependence on consensus-based guidelines. This article focuses on the Italian Association for the Study of the Liver guidelines and the Japanese approaches to therapy, while drawing attention to certain controversies from other academic bodies where applicable and appropriate.Entities:
Keywords: Hepatocellular carcinoma; Practice guideline; Treatment; Treatment algorithm
Year: 2016 PMID: 27995084 PMCID: PMC5159738 DOI: 10.1159/000449343
Source DB: PubMed Journal: Liver Cancer ISSN: 1664-5553 Impact factor: 11.740